🇺🇸 FDA

Intelligence Platform

Patents

Browse 389 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9090873

Development of dengue virus vaccine components

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9085604

Antiproliferative factor and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9068165

Therapeutic applications of P53 isoforms in regenerative medicine, aging and cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9046520

Serologic correlates of protection against Bacillis anthracis infection

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9044457

Anti-DR4 agonist antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9012618

Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity whi

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9006203

Method of reducing inflammatory infiltration in subjects with inflammatory lung disease

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9005631

Membrane proximal region of HIV gp41 anchored to the lipid layer of a virus-like particle

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9000141

Localization and characterization of flavivirus envelope glycoprotein cross-reactive epito

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8957015

Tumor suppressor gene p47ING3

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8940700

E-selectin compositions and use thereof for inducing E-selectin tolerance

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8926986

Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8927030

Use of nitrite salts for the treatment of cardiovascular conditions

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8921071

Targeting poly-gamma-glutamic acid to treat Staphylococcus epidermidis and related infecti

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8911728

High-affinity fully functional soluble single-domain human CD4, antibodies, and related fu

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8906358

Leishmania challenge model

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8901093

Custom vectors for treating and preventing pancreatic cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8895521

Methods and compositions for the treatment of uveitis

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8877213

Live attenuated Leishmania vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8877765

Highly soluble pyrimido-dione-quinoline compounds and their use in the treatment of cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8877199

B cell surface reactive antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8871191

Use of IL-15 preparations to treat lymphopenia

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865880

Identification of a novel BHD gene

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8858946

Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted